xolair
novartis indonesia - indonesia - omalizumab - serbuk injeksi - 150 mg
xolair
novartis indonesia - indonesia - omalizumab - serbuk injeksi - 150 mg
spiriva respimat
boehringer ingelheim indonesia - indonesia - tiotropium bromide - cairan inhalasi - 3,124 mcg
spiriva respimat
boehringer ingelheim indonesia - indonesia - tiotropium bromide - cairan inhalasi - 3,124 mcg
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
humira
abbott indonesia - indonesia - adalimumab - cairan injeksi - 40 mg
humira
abbott indonesia - indonesia - adalimumab - cairan injeksi - 40 mg/0,8 ml
hemlibra
boehringer ingelheim indonesia - indonesia - emicizumab - cairan injeksi - 30 mg/ml
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 105 mg